Carnivore Diet and High LDL Cholesterol: An Honest Look at the Evidence

If you start a carnivore diet and your next blood panel shows your LDL cholesterol has climbed — sometimes a lot — you are not imagining it, and you are not alone. Rising LDL is the single most common lab change people report on this diet, and it is the objection that stops more people from trying it than any other.

This article does not tell you that high LDL does not matter. It also does not tell you that a carnivore diet will give you a heart attack. Both of those are overconfident claims that go beyond what the evidence actually supports. Instead, this is an honest map of what is known, what is genuinely debated, and what a thoughtful person can do about a rising LDL number. If you want certainty, no honest source can give it to you here yet. If you want to make an informed decision, read on.

First: Yes, LDL Often Rises on Carnivore

This is not speculation. A small 2025 exploratory study of people in Germany following a self-directed carnivore diet found that total and LDL cholesterol "increased significantly" — median total cholesterol rose from roughly 224 to 305 mg/dL and LDL from roughly 157 to 256 mg/dL over the period studied, while most other blood markers stayed stable (Klement & Matzat, 2025). The sample was tiny (around two dozen self-selected people, with paired before/after cholesterol panels on roughly 14–18 of them) and uncontrolled, so it cannot tell us anything about safety — but it confirms the pattern that practitioners describe constantly: cut the carbs to near zero, eat mostly fatty animal foods, and for many people LDL goes up.

For some individuals the rise is dramatic. A 2022 case report described a lean, healthy 26-year-old man whose LDL climbed from 95 to a peak of 545 mg/dL on a carbohydrate-restricted diet (Norwitz et al. case report, 2022). That is one person — an n-of-1 — but it illustrates how large the response can be in certain people.

So the question is not whether LDL rises. For a large share of people, it does. The real question is what that rise means for them.

The "Lean Mass Hyper-Responder" Hypothesis

Out of cases like the one above came a proposed framework: the Lean Mass Hyper-Responder (LMHR) phenotype. The idea, developed by researchers including Nick Norwitz and Dave Feldman, describes a recurring pattern in lean, active, metabolically healthy, insulin-sensitive people on low-carbohydrate diets: a striking triad of very high LDL cholesterol, high HDL cholesterol (often above 80–100 mg/dL), and low triglycerides (often below 70 mg/dL).

The proposed mechanism is sometimes called the Lipid Energy Model (Norwitz et al., Metabolites, 2022). In simplified terms: when you remove dietary carbohydrate, your body has to ship a lot of fat around the bloodstream for fuel. That fat travels packaged in lipoproteins, and the model proposes that in lean, insulin-sensitive people this increased fat-trafficking shows up as higher LDL — more as a marker of fat being used for energy than of fat accumulating in artery walls. Proponents point to the favorable HDL and triglyceride numbers, and to some imaging in selected individuals, as reasons to think this particular pattern may not carry the same risk as high LDL in, say, someone with metabolic syndrome.

It is a genuinely interesting hypothesis. It is also exactly that — a hypothesis.

The Other Side: Why Many Researchers Are Not Convinced

Here is the part most carnivore-friendly articles leave out. The LMHR idea has been directly challenged in the scientific literature. A 2022 rebuttal (Moore et al., Current Developments in Nutrition) argued that the evidence for a distinct, benign "hyper-responder" phenotype is lacking, and that clinically significant increases in LDL occur across all body-composition categories on carbohydrate restriction — not just in some special protected group.

This sits on top of a much larger and well-established body of cardiology: LDL cholesterol (and the particle-count measure ApoB) is one of the most thoroughly documented causal risk factors for atherosclerotic cardiovascular disease in the general population — the position of the 2017 European Atherosclerosis Society consensus statement (Ference et al.), built on genetic, epidemiologic, and clinical evidence. That body of evidence is not erased by a low-carb diet, and no one has yet shown that the LMHR pattern is exempt from it.

The honest summary of the skeptical position: a high LDL is a high LDL, the long-term consequences of deliberately driving it very high are unknown, and "my triglycerides look great" is reassuring but not proof of cardiovascular safety.

What the Evidence Does Not Show (in Either Direction)

This is the crux, and it is uncomfortable for partisans on both sides:

• No study has shown that LMHR-pattern individuals are protected from heart disease. The favorable HDL/triglyceride profile is a reasonable basis for a hypothesis, not an outcome.
• No study has shown that a carnivore-diet-induced LDL rise causes heart attacks either. The long-term cardiovascular-outcome trials simply have not been done in this specific population.

What exists today is short-term data, mechanistic argument, case reports, and small uncontrolled studies. That means anyone — influencer or doctor — who tells you the answer with confidence is going beyond the evidence. The intellectually honest position is uncertainty, and the responsible response to uncertainty about your own heart is to measure, monitor, and decide with a professional rather than to either panic or dismiss.

What to Actually Do If Your LDL Rises

This is not medical advice, and the right path depends on your overall risk profile — but here is the framework a careful person can bring to their clinician:

1. Get the full picture, not just LDL-C. Ask about ApoB (a direct count of atherogenic particles, often more informative than LDL-C), along with HDL, triglycerides, and a fasting glucose / HbA1c. The pattern matters, not one number alone. For a deeper walkthrough of each marker, see our carnivore lipid panel explainer.
2. Consider a coronary artery calcium (CAC) score. It is a low-radiation CT scan that measures calcified plaque already in your arteries — a direct look at whether disease is present, rather than a prediction. Many people use a baseline CAC and a repeat in a few years to see whether anything is actually progressing. Discuss whether it is appropriate for you.
3. Know your other risk factors. Family history, blood pressure, smoking status, insulin resistance, and inflammation markers all change how much a given LDL number should concern you. A rise in an otherwise low-risk person is a different conversation than the same rise alongside hypertension and a strong family history.
4. Talk to a clinician who will actually engage with the data — ideally one willing to look at ApoB and a CAC score rather than reacting to LDL-C in isolation. If your number has risen substantially, this is a conversation to have, not a thing to file away.
5. Remember you have levers. Some people moderate the LDL rise by adjusting the type of fat (for example, shifting some saturated fat toward monounsaturated sources) without abandoning the diet. Whether that is worth doing is, again, an individual decision made with your numbers in front of you.

The goal is not to win an internet argument about whether LDL matters. It is to make sure that you, specifically, are not quietly accumulating cardiovascular risk — and the only way to know that is to look.

A Note on Individual Risk

This article is educational and is not a substitute for personalized medical advice. Cardiovascular risk is individual, and a rising LDL on a carnivore diet should be discussed with a qualified clinician — especially if you have a personal or family history of heart disease, high blood pressure, diabetes, or other risk factors, or if you take any medication. Do not start, stop, or change a diet or a medication based on a blog article. The most pro-carnivore thing and the most pro-health thing are the same thing here: know your numbers.

Frequently Asked Questions

Sources

Clinical citations independently verified 2026-05-30. Study type is stated because it determines how strong a claim each source can support.

1. Norwitz NG, et al. (2022). "Hypercholesterolemia 'Lean Mass Hyper-Responder' Phenotype Presents in the Context of a Low Saturated Fat Carbohydrate-Restricted Diet." Frontiers in Endocrinology. Case report (n=1). Supports: one lean 26-y-o male's LDL rose 95→545 mg/dl peak on carb restriction (origin of the LMHR triad description). Cannot support population-level or safety claims. PMC9048595 — https://pmc.ncbi.nlm.nih.gov/articles/PMC9048595/
2. Moore JM, et al. (2022). "Evidence for a Lean Mass Hyperresponder Phenotype Is Lacking with Increases in LDL Cholesterol of Clinical Significance in All Categories of Response to a Carbohydrate-Restricted Diet." Current Developments in Nutrition. Letter / critical commentary. Used here as the SKEPTICAL counter-view: argues LMHR evidence is weak and significant LDL rises occur across all body-composition categories. PMC9154228 — https://pmc.ncbi.nlm.nih.gov/articles/PMC9154228/
3. Klement RJ & Matzat JS (2025). "Subjective Experiences and Blood Parameter Changes in Individuals From Germany Following a Self-Conceived 'Carnivore Diet': An Explorative Study." Cureus 17(4):e82521. Explorative observational (~24 self-selected, uncontrolled; paired cholesterol panels on ~14–18). Supports: total & LDL cholesterol rose significantly (total median ~224→305 mg/dL; LDL ~157→256 mg/dL); most other markers stable. Hypothesis-generating only; cannot support safety/efficacy. PMC12085909 — https://pmc.ncbi.nlm.nih.gov/articles/PMC12085909/
4. Norwitz NG, Soto-Mota A, Kaplan B, Ludwig DS, Budoff M, Kontush A, Feldman D (2022). "The Lipid Energy Model: Reimagining Lipoprotein Function in the Context of Carbohydrate-Restricted Diets." Metabolites 12(5):460. Proposed mechanistic model. Supports: the proposed mechanism by which lean, metabolically healthy people on carbohydrate-restricted diets develop elevated LDL (the "Lean Mass Hyper-Responder" pattern). A model, not outcome evidence. PMID 35629964 / PMC9147253 — https://pmc.ncbi.nlm.nih.gov/articles/PMC9147253/
5. Ference BA, Ginsberg HN, Graham I, et al. (2017). "Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel." European Heart Journal 38(32):2459–2472. Consensus statement. Supports: LDL is a causal risk factor for atherosclerotic cardiovascular disease — the mainstream position this article does not contest. PMID 28444290 — https://pubmed.ncbi.nlm.nih.gov/28444290/